Vantage
Payments companies reported to CMS as associated with Vantage. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vantage, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vantage
These are the largest totals companies reported as associated with Vantage. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Nunley | Durham, NC | Orthopaedic Surgery | $563,281.79 |
| Mark Easley | Durham, NC | Orthopaedic Surgery | $541,084.36 |
| James Deorio | Durham, NC | Orthopaedic Surgery | $519,540.31 |
| Edward Haupt | Jacksonville, FL | Orthopaedic Surgery | $175,935.72 |
| Oliver Schipper | Arlington, VA | Foot and Ankle Surgery | $132,255.05 |
| John Schuberth | San Francisco, CA | Foot & Ankle Surgery | $116,196.83 |
| Constantine Demetracopoulos | New York, NY | Foot and Ankle Surgery | $108,511.40 |
| James Lachman | Quakertown, PA | Foot and Ankle Surgery | $89,382.59 |
| Sara Miniaci-Coxhead | Cleveland, OH | Foot and Ankle Surgery | $85,622.09 |
| Matthew Deorio | Huntsville, AL | Foot and Ankle Surgery | $41,162.73 |
Prescribed Vantage?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.